Abstract
BackgroundTreatment for Multi-Drug Resistant Tuberculosis (MDR-TB) is long and costly. Currently, there are limited effective and affordable treatment response monitoring tools. We set to evaluate the performance of alternative bacteriological...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
